Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicola Cove"'
Autor:
Moire Cuncannon, Matthew Wong, Dasantha Jayamanne, Linxin Guo, Nicola Cove, Helen Wheeler, Michael Back
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Assess benefit of salvage bevacizumab (BEV) at time of symptomatic progression in patients with refractory glioblastoma (GBM). Methods Patients managed with adjuvant long course chemo-radiation therapy for GBM were entered into a
Externí odkaz:
https://doaj.org/article/a109735e78d6477088affd6f97aed1f5
Autor:
Michael Back, Dasantha Jayamanne, Nicola Cove, Helen Wheeler, Mustafa Khasraw, Linxin Guo, Jemimah Back, Matthew Wong
Publikováno v:
Brain Sciences, Vol 8, Iss 10, p 186 (2018)
Delivery of highly sophisticated, and subspecialised, management protocols for glioblastoma in low volume rural and regional areas creates potential issues for equivalent quality of care. This study aims to demonstrate the impact on clinical quality
Externí odkaz:
https://doaj.org/article/a0d09eefef0246dd8aaed174c76aaf81
Autor:
Nicola Cove, Michael Back, Matthew Wong, Marina Kastelan, Raymond J. Cook, Theresa A Cook, Dasantha Jayamanne, Chris Brown, Jonathon Parkinson, Helen Wheeler
Publikováno v:
Neurooncol Pract
Background There is minimal evidence to support decision making for symptomatic steroid-refractory pseudoprogression or true progression occurring after intensity-modulated radiation therapy (IMRT) for glioblastoma (GBM). This study audited the survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f4b7668b945bf4d6802da8828c7d00
https://doi.org/10.1093/nop/npab034
https://doi.org/10.1093/nop/npab034
Autor:
Jemimah Back, Mustafa Khasraw, Dasantha Jayamanne, Michael Back, Nicola Cove, Matthew Wong, Linxin Guo, Helen Wheeler
Publikováno v:
Brain Sciences
Volume 8
Issue 10
Brain Sciences, Vol 8, Iss 10, p 186 (2018)
Volume 8
Issue 10
Brain Sciences, Vol 8, Iss 10, p 186 (2018)
Delivery of highly sophisticated, and subspecialised, management protocols for glioblastoma in low volume rural and regional areas creates potential issues for equivalent quality of care. This study aims to demonstrate the impact on clinical quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8977517ca48073127cace50d7f01a2c
Autor:
Matthew Wong, Linxin Guo, Helen Wheeler, Dasantha Jayamanne, Moire Cuncannon, Michael Back, Nicola Cove
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Background Assess benefit of salvage bevacizumab (BEV) at time of symptomatic progression in patients with refractory glioblastoma (GBM). Methods Patients managed with adjuvant long course chemo-radiation therapy for GBM were entered into a prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e07a898ede75556c79e9fadd3bd5a8d
https://pubmed.ncbi.nlm.nih.gov/31088401
https://pubmed.ncbi.nlm.nih.gov/31088401